Declining CA-125 in an Ovarian Cancer Patient with Progression of Measurable Disease: A Rational Hypothesis for Discordant Results

By Markman M.   Kennedy A.   Webster K.   Peterson G.   Kulp B.   Belinson J.  

Gynecologic Oncology, Vol. 77, Iss. 2, 2000-05 ,pp. : 321-322

Elsevier

Access to resources Recommend Favorite

Ovarian Cancer-A Challenging Disease

By Einhorn N.  

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 10-13

Academic Press

Access to resources Recommend Favorite

Hereditary Ovarian Cancer: A Different Disease?

By Daly M.B.  

Gynecologic Oncology, Vol. 66, Iss. 1, 1997-07 ,pp. : 1-2

Elsevier

Access to resources Recommend Favorite

Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors

By Rasmussen Christina   Faber Mette   Jensen Allan   Høgdall Estrid   Høgdall Claus   Blaakær Jan   Kjaer Susanne  

Cancer Causes and Control, Vol. 24, Iss. 7, 2013-07 ,pp. : 1459-1464

Springer Publishing Company

Access to resources Recommend Favorite

Characterization of disease progression in ovarian cancer by utilizing ‘chemograms’ of ovarian cancer stem cells

By Guddati Achuta K   Shaheen Shagufta  

Journal of Chemotherapy, Vol. 25, Iss. 3, 2013-06 ,pp. : 184-191

Maney Publishing

Access to resources Recommend Favorite